Juan Antonio Ballesteros Nobell
Gründer bei Vivia Biotech SL
Profil
Juan Antonio Ballesteros Nobell is the founder.
He founded Novasite Pharmaceuticals, Inc. in 1999 and currently holds the title of Chief Scientific Officer & Partner.
He also founded Vivia Biotech SL in 2005 and currently holds the title of Chairman & Chief Scientific Officer.
In terms of education, Dr. Ballesteros Nobell holds a doctorate degree from New York University and an undergraduate degree from the University of Barcelona.
Aktive Positionen von Juan Antonio Ballesteros Nobell
| Unternehmen | Position | Beginn |
|---|---|---|
Vivia Biotech SL
 Vivia Biotech SL BiotechnologyHealth Technology Vivia Biotech SL provides biotechnology research services and laboratory instruments. It is a research and development company that focuses on the drug effects on hematological cancer patients. The firm provides personalized medicine test for blood cancers that can help predict the patient's response to treatment prior to its administration. The company was founded by Juan Antonio Ballesteros Nobell, Andrés Ballesteros Nobell and Fernando Rodríguez de Fonseca in September 2007 and is headquartered in Tres Cantos, Spain. | Gründer | 04.05.2005 |
Novasite Pharmaceuticals, Inc.
 Novasite Pharmaceuticals, Inc. BiotechnologyHealth Technology Novasite Pharmaceuticals, Inc. develops optimizing genes and proteins. The private company is based in San Diego, CA and has subsidiaries in United States. The company was founded by Juan Antonio Ballesteros Nobell. | Gründer | 16.12.2009 |
Ausbildung von Juan Antonio Ballesteros Nobell
| University of Barcelona | Undergraduate Degree |
| New York University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Vivia Biotech SL
Vivia Biotech SL BiotechnologyHealth Technology Vivia Biotech SL provides biotechnology research services and laboratory instruments. It is a research and development company that focuses on the drug effects on hematological cancer patients. The firm provides personalized medicine test for blood cancers that can help predict the patient's response to treatment prior to its administration. The company was founded by Juan Antonio Ballesteros Nobell, Andrés Ballesteros Nobell and Fernando Rodríguez de Fonseca in September 2007 and is headquartered in Tres Cantos, Spain. | Health Technology |
Novasite Pharmaceuticals, Inc.
Novasite Pharmaceuticals, Inc. BiotechnologyHealth Technology Novasite Pharmaceuticals, Inc. develops optimizing genes and proteins. The private company is based in San Diego, CA and has subsidiaries in United States. The company was founded by Juan Antonio Ballesteros Nobell. | Health Technology |
